4.2 Article

Novel FBN1 gene mutation and maternal germinal mosaicism as the cause of neonatal form of Marfan syndrome

期刊

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 164, 期 6, 页码 1559-1564

出版社

WILEY
DOI: 10.1002/ajmg.a.36480

关键词

neonatal Marfan syndrome; FBN1; fibrillin-1; splicing; splicing mutation

资金

  1. UNCE [204011]
  2. IGA MZ CR [NT14156-3/2013]
  3. Charles University, Prague [SVV-266505/2013]
  4. Centre for Cardiovascular Surgery and Transplantation, Brno [201209]
  5. CEITEC-Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]

向作者/读者索取更多资源

Marfan syndrome (MFS) is an autosomal dominant disorder caused by mutations in the fibrillin 1 gene (FBN1). Neonatal form of MFS is rare and is associated with severe phenotype and a poor prognosis. We report on a newborn girl with neonatal MFS who displayed cyanosis and dyspnea on the first day of life. The main clinical features included mitral and tricuspid valve insufficiency, aortic root dilatation, arachnodactyly, and loose skin. Despite the presence of severe and inoperable heart anomalies, the girl was quite stable on symptomatic treatment and lived up to the 7th month of age when she died due to cardiorespiratory failure. Molecular-genetic studies revealed a novel intronic c.4211-32_-13del mutation in the FBN1 gene. Subsequent in vitro splicing analysis showed this mutation led to exon 35 skipping, presumably resulting in a deletion of 42 amino acids (p.Leu1405_Asp1446del). Interestingly, this mutation is localized outside the region of exons 24-32, whose mutation is responsible for the substantial majority of cases of neonatal MFS. Although the family history of MFS was negative, the subsequent molecular genetic examination documented a mosaicism of the same mutation in the maternal blood cells (10-25% of genomic DNA) and the detailed clinical examination showed unilateral lens ectopy. (c) 2014 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

The reduced use of invasive procedures leads to a change of frequencies of prenatally detected chromosomal aberrations: population data from the years 2012-2016

Antonin Sipek, Vladimir Gregor, Antonin Sipek, Jan Klaschka, Marek Maly, Pavel Calda

Summary: This study analyzed the screening results of a population with a high rate of first-trimester screening and a low rate of cell-free DNA testing for chromosomal aberrations. The study found an increase in major autosomal trisomies and a decrease in other chromosomal aberrations, as well as a reduction in the use of invasive diagnostic procedures.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Immunology

Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates

Juraj Bosak, Matej Lexa, Kristyna Fiedorova, Darshak C. Gadara, Lenka Micenkova, Zdenek Spacil, Jiri Litzman, Tomas Freiberger, David Smajs

Summary: CVID patients exhibit an expanded bacterial diversity and dysregulation in metabolic pathways in the gut microbiome, indicating potential diagnostic and prognostic markers for CVID in the future.

FRONTIERS IN IMMUNOLOGY (2021)

Article Microbiology

Actinotignum schaalii: Relation to Concomitants and Connection to Patients' Conditions in Polymicrobial Biofilms of Urinary Tract Catheters and Urines

Iva Kotaskova, Vit Syrovatka, Hana Obrucova, Petra Videnska, Barbora Zwinsova, Veronika Hola, Eva Blastikova, Filip Ruzicka, Tomas Freiberger

Summary: The study analyzed the prevalence of A. schaalii in urine samples, finding that A. schaalii-positive samples were more diverse and related to other bacteria. A. schaalii may be associated with certain bacterial species, while being mutually exclusive with others.

MICROORGANISMS (2021)

Article Genetics & Heredity

The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification

Joana R. Chora, Michael A. Iacocca, Lukas Tichy, Hannah Wand, C. Lisa Kurtz, Heather Zimmermann, Annette Leon, Maggie Williams, Steve E. Humphries, Amanda J. Hooper, Mark Trinder, Liam R. Brunham, Alexandre Costa Pereira, Cinthia E. Jannes, Margaret Chen, Jessica Chonis, Jian Wang, Serra Kim, Tami Johnston, Premysl Soucek, Michal Kramarek, Sarah E. Leigh, Alain Carrie, Eric J. Sijbrands, Robert A. Hegele, Tomas Freiberger, Joshua W. Knowles, Mafalda Bourbon

Summary: This study provides consensus recommendations for the classification of LDLR variants in Familial Hypercholesterolemia (FH) based on modified guidelines. The establishment of these guidelines as the new standard can improve the accuracy and consistency of LDLR variant classification, thereby enhancing the care of patients with FH.

GENETICS IN MEDICINE (2022)

Article Medicine, General & Internal

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo-Vaz, Kausik K. Ray, Handrean Soran, Tomas Freiberger, Stefano Bertolini, Mariko Harada-Shiba, Dirk J. Blom, Frederick J. Raal, Marina Cuchel

Summary: Patients with homozygous familial hypercholesterolaemia (HoFH) globally face issues of late diagnosis, under-treatment, and high risk of premature ASCVD. The use of multiple lipid-lowering therapy regimens is associated with lower LDL cholesterol levels and better outcomes. Significant global disparities exist in treatment regimens, control of LDL cholesterol levels, and cardiovascular event-free survival.

LANCET (2022)

Article Clinical Neurology

Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease

Jitka Majovska, Anita Hennig, Igor Nestrasil, Susanne A. Schneider, Helena Jahnova, Manuela Vaneckova, Martin Magner, Petr Dusek

Summary: Late-onset Tay-Sachs disease is a rare autosomal recessive neurodegenerative disorder characterized by slowly progressive cerebellar ataxia, lower motor neuron disease, and psychiatric impairment. On brain MRI, pontocerebellar atrophy is a constant finding in LOTS patients. These characteristic clinical and MRI findings can help in the differential diagnosis of adult-onset cerebellar ataxias.

NEUROLOGICAL SCIENCES (2022)

Article Genetics & Heredity

Pitfalls of X-chromosome inactivation testing in females with Fabry disease

Martin Reboun, Jakub Sikora, Martin Magner, Helena Wiederlechnerova, Alena Cerna, Helena Poupetova, Gabriela Storkanova, Dita Musalkova, Gabriela Dostalova, Lubor Golan, Ales Linhart, Lenka Dvorakova

Summary: This study aimed to evaluate X-chromosome inactivation (XCI) testing in female Fabry disease (FD) patients. The results showed that combining multiple testing methods generates more reliable results, correlating XCI with gene expression and enzyme activity helps identify crossover events, and age and tissue-specific patterns should be considered.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Genetics & Heredity

The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers

Anna Tylki-Szymanska, Zsuzsanna Almassy, Violetta Christophidou-Anastasiadou, Daniela Avdjieva-Tzavella, Ingeborg Barisic, Rimante Cerkauskiene, Goran Cuturilo, Maja Djiordjevic, Zoran Gucev, Anna Hlavata, Beata Kiec-Wilk, Martin Magner, Ivan Pecin, Vasilica Plaiasu, Mira Samardzic, Dimitrios Zafeiriou, Ioannis Zaganas, Christina Lampe

Summary: This study analyzed the management and treatment of mucopolysaccharidoses (MPS), a group of lysosomal storage disorders, in Southern and Eastern European countries. The results showed that the region has a high number of MPS patients and a high level of care. However, there are challenges in implementing enzyme replacement therapy (ERT) and conducting certain assessments due to a lack of skilled specialists. The study suggests simplifying the availability and reimbursement of ERT and implementing educational programs for specialists.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Genetics & Heredity

A Novel MTTK Gene Variant m.8315A>C as a Cause of MERRF Syndrome

Hana Stufkova, Hana Kolarova, Katerina Lokvencova, Tomas Honzik, Jiri Zeman, Hana Hansikova, Marketa Tesarova

Summary: In this study, a new pathogenic variant in mitochondrial DNA was discovered, associated with symptoms including myoclonus, epilepsy, muscle weakness, and hearing impairment. The variant was found in the MTTK gene with a mutation load ranging from 71% to >96% in tested tissues. The study also revealed decreased respiratory chain complex activities in muscle mitochondria. This finding expands the spectrum of MTTK variants associated with mitochondrial encephalopathies in adults.
Review Health Care Sciences & Services

Hearing Loss in Patients With Morquio Syndrome: Protocol for a Scoping Review

Lorena Diaz-Ordonez, Estephania Candelo, Katherine Silva-Cuero, Wilmar Saldarriaga, Lenka Murgasova, Martin Magner, Harry Pachajoa

Summary: This scoping review aims to understand the evidence regarding the pathophysiology, classification, epidemiology, and clinical management of hearing loss in MPS IVA patients, as well as the effect of therapy for hearing loss. The review will gather relevant literature and analyze the data for descriptive reporting.

JMIR RESEARCH PROTOCOLS (2022)

Article Genetics & Heredity

GABBR1 monoallelic de novo variants linked to neurodevelopmental delay and epilepsy

Maria Lucia Cediel, Michal Stawarski, Xavier Blanc, Lenka Noskova, Martin Magner, Konrad Platzer, Janina Gburek-Augustat, Dustin Baldridge, John N. Constantino, Emmanuelle Ranza, Bernhard Bettler, Stylianos E. Antonarakis

Summary: GABA(B) receptors are responsible for neuronal inhibition in the central nervous system. Variants in GABBR2 have been associated with certain phenotypes, while no phenotypes have been established for GABBR1 variants. This study identified four GABBR1 variants in individuals with motor and/or language delay, and functional characterization revealed their impact on GABA potency and efficacy, providing insights into disease severity and potential therapeutic strategies.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Endocrinology & Metabolism

Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa

John J. Mitchell, Barbara K. Burton, Michael B. Bober, Philippe M. Campeau, Shelda Cohen, Sara Dosenovic, Carolyn Ellaway, Kaustuv Bhattacharya, Nathalie Guffon, David Hinds, Alice Lail, Shuan-Pei Lin, Martin Magner, Julian Raiman, Liat Schwartz-Sagi, Karolina M. Stepien

Summary: The Morquio A Registry Study (MARS) is an ongoing multinational observational study that aims to characterize the disease heterogeneity and natural history of MPS IVA and evaluate the long-term effectiveness and safety of elosulfase alfa enzyme replacement therapy (ERT). The study has enrolled 381 subjects from 17 countries, and the data collected over the first 6 years show that ERT treatment can stabilize endurance and respiratory function without new safety concerns.

MOLECULAR GENETICS AND METABOLISM (2022)

Review Cardiac & Cardiovascular Systems

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

Samuel S. Gidding, Albert Wiegman, Urh Groselj, Tomas Freiberger, Noel Peretti, Kanika Dharmayat, Magdalena Daccord, Nicola Bedlington, Jaka Sikonja, Kausik K. Ray, Raul D. Santos, Martin Halle, Lale Tokgozoglu, Inaki Gutierrez-Ibarluzea, Fausto J. Pinto, Marius Geanta

Summary: Familial hypercholesterolaemia (FH) is often overlooked and undertreated in Europe, resulting in increased risk of premature heart disease. Early treatment is effective in preventing heart disease and cost-effective. The European Commission Public Health Best Practice Portal recognizes FH screening as an effective strategy. Model programs in Europe employ cascade screening, universal screening, opportunistic screening, or a combination of these approaches to identify young individuals with FH. Recommendations to improve FH identification emphasize the need for screening programs in every country, adapted to fit the healthcare system, with financial support from governments and further research for optimization.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Article Genetics & Heredity

Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype

Susan M. Hiatt, Slavica Trajkova, Matteo Rossi Sebastiano, E. Christopher Partridge, Fatima E. Abidi, Ashlyn Anderson, Muhammad Ansar, Stylianos E. Antonarakis, Azadeh Azadi, Ruxandra Bachmann-Gagescu, Andrea Bartuli, Caroline Benech, Jennifer L. Berkowitz, Michael J. Betti, Alfredo Brusco, Ashley Cannon, Giulia Caron, Yanmin Chen, Meagan E. Cochran, Tanner F. Coleman, Molly M. Crenshaw, Laurence Cuisset, Cynthia J. Curry, Hossein Darvish, Serwet Demirdas, Maria Descartes, Jessica Douglas, David A. Dyment, Houda Zghal Elloumi, Giuseppe Ermondi, Marie Faoucher, Emily G. Farrow, Stephanie A. Felker, Heather Fisher, Anna C. E. Hurst, Pascal Joset, Melissa A. Kelly, Stanislav Kmoch, Benjamin R. Leadem, Michael J. Lyons, Marina Macchiaiolo, Martin Magner, Giorgia Mandrile, Francesca Mattioli, Megan McEown, Sarah K. Meadows, Livija Medne, Naomi J. L. Meeks, Sarah Montgomery, Melanie P. Napier, Marvin Natowicz, Kimberly M. Newberry, Marcello Niceta, Lenka Noskova, Catherine B. Nowak, Amanda G. Noyes, Matthew Osmond, Eloise J. Prijoles, Jada Pugh, Verdiana Pullano, Chloe Quelin, Simin Rahimi-Aliabadi, Anita Rauch, Sylvia Redon, Alexandre Reymond, Caitlin R. Schwager, Elizabeth A. Sellars, Angela E. Scheuerle, Elena Shukarova-Angelovska, Cara Skraban, Elliot Stolerman, Bonnie R. Sullivan, Marco Tartaglia, Isabelle Thiffault, Kevin Uguen, Luis A. Umana, Yolande van Bever, Saskia N. van der Crabben, Marjon A. van Slegtenhorst, Quinten Waisfisz, Camerun Washington, Lance H. Rodan, Richard M. Myers, Gregory M. Cooper

Summary: Using the MatchMaker Exchange, researchers identified rare protein-altering variations in the ZMYM3 gene in a cohort of 27 individuals with neurodevelopmental disorders (NDDs). These variations affected protein structure and function and were associated with developmental delay, intellectual disability, behavioral abnormalities, and specific facial features. The evidence from evolutionary conservation, protein modeling, and functional experiments strongly supports ZMYM3 as an NDD-associated gene.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Nutrition & Dietetics

Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study

Martin Magner, Katerina Thorova, Veronika Zupova, Milan Houska, Ivana Svandova, Pavla Novotna, Jan Triska, Nadezda Vrchotova, Ivo Soural, Ladislav Jilek

Summary: This study examined the effects of sulforaphane on autistic behavior in children aged 3-7 years with autism spectrum disorder. However, the results showed no significant improvement in the behavioral outcome measures after 36 weeks of treatment with sulforaphane.

NUTRIENTS (2023)

暂无数据